Terry Bice

Terry Bice serves as a key procurement lead within the W4PZ USA Medical Research Acquisition Act, operating under the Department of the Army, where they oversee the acquisition of advanced biomedical technologies and analytical systems critical to warfighter health and operational readiness. Responsible for managing complex research and development contracts, Bice specializes in translating laboratory innovations into field-deployable medical solutions, with a focus on diagnostic instrumentation, clinical software, and supporting IT infrastructure. Their procurement activities align directly with the agency’s mission to accelerate the transition of cutting-edge life sciences research into practical military medical capabilities, ensuring acquisitions meet rigorous technical and operational standards for expeditionary environments. Bice cultivates strategic partnerships with a diverse range of vendors, including specialized manufacturers of surgical and analytical instruments, software publishers developing clinical decision-support tools, and service providers delivering custom computational and data analytics solutions. While no single contractor dominates the portfolio, their contracting patterns reflect a preference for technical excellence and innovation over volume, engaging both established defense contractors and niche technology firms capable of rapid prototyping and validation under military constraints. Bice’s procurement approach reflects a strong preference for open competition, with 100% of awards issued under non-set-aside authorities. This indicates a focus on technical merit and capability over socioeconomic categorization, though small businesses remain eligible and competitive within the broader pool. The absence of set-asides suggests an emphasis on mission-critical performance and speed of delivery over socioeconomic targets. The primary NAICS focus areas—Surgical and Medical Instrument Manufacturing, Software Publishers, and Other Computer Related Services—reveal a deep specialization in diagnostic equipment, biomedical software, and analytical laboratory systems. Bice’s portfolio consistently targets high-precision instruments, data-driven health analytics platforms, and integrated clinical computing systems essential for forward-deployed medical units and combat casualty care.